Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

Science Watch logo

JID Article Named "New Hot Paper" by ScienceWatch.com

Dr. Lauri Hicks' 2007 article on pneumococcal disease has been named a "hot new paper" by Thompson Reuters' ScienceWatch.com. Read a Q&A about the article with Dr. Hicks here

Press Release

Unique Collaboration Charts the Migrations of a Parasite that Affected History
Researchers Sequence Louse DNA from Mummies and Propose New Model for its Development


In the News

Featured in Grist
"Another symptom of swine flu: instant amnesia" May 11, 2009
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Read the veterinary literature on swine flu and you get a strong sense of what might be called vaccination treadmill: the hog industry is literally scrambling to generate new vaccines for the rapidly evolving flu strains that sweep through CAFOs. Writing in the Journal of Infectious Diseases [PDF] in 2008, Eileen Thacker and Bruce Janke of Iowa State University paint a stark picture: “A number of genetically diverse viruses are circulating in swine herds throughout the world and are a major cause of concern to the swine industry,” they write. “Influenza virus infections in swine and poultry are potential sources of viruses for the next pandemic among humans.”

Featured in New York Times
"Fear of a Swine Flu Epidemic in 1976 Offers Some Lessons, and Concerns, Today" May 8, 2009
Anti‐Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine‐Associated Guillain‐Barré Syndrome
Irving Nachamkin, Sean V. Shadomy, Anthony P. Moran, Nancy Cox, Collette Fitzgerald, Huong Ung, Adrian T. Corcoran, John K. Iskander, Lawrence B. Schonberger, and Robert T. Chen
Irving Nachamkin, a professor of pathology and laboratory medicine at the University of Pennsylvania, examined some 1976 vaccine that had been saved by a scientist in Texas. In a paper published last year in The Journal of Infectious Diseases, he and colleagues reported that mice given the vaccine made antibodies that reacted with gangliosides, which are components of nerve cells. An antibody attack on gangliosides is part of the disease mechanism of Guillain-Barré.

Featured in AFP
"Swine flu vaccine 'could be ready soon'" May 7, 2009
A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses
Mary A. Hoelscher, Neetu Singh, Sanjay Garg, Lakshmi Jayashankar, Vic Veguilla, Aseem Pandey, Yumi Matsuoka, Jacqueline M. Katz, Ruben Donis, Suresh K. Mittal, and Suryaprakash Sambhara
The vaccine Mittal created for the bird flu worked on three different strains isolated over a seven-year period and was described in papers for the Journal of Infectious Diseases and the journal Clinical Pharmacology and Therapeutics.

Featured in Newsweek
"The Path of a Pandemic" http://www.newsweek.com/id/195692
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Last year researchers from Iowa State University in Ames warned that pigs located in industrial-scale farms were being subjected to influenza infections from farm poultry, wild birds and their human handlers. Writing in The Journal of Infectious Diseases, Eileen Thacker and Bruce Janke said, "As a result of the constantly changing genetic makeup of individual influenza viruses in pigs, the U.S. swine industry is continually scrambling to respond to the influenza viruses circulating within individual production systems."

1 September 2006

Volume 194, Number 5
The Journal of Infectious Diseases 2006;194:561–570
0022-1899/2006/19405-0005$15.00
DOI: 10.1086/506455
MAJOR ARTICLE

Transmission of Herpes Simplex Virus Types 1 and 2 in a Prospective Cohort of HIV‐Negative Gay Men: The Health in Men Study

Fengyi Jin,1

Garrett P. Prestage,1

Limin Mao,2

Susan C. Kippax,2

Catherine M. Pell,6

Basil Donovan,1,3

David J. Templeton,1

Janette Taylor,5

Adrian Mindel,4

John M. Kaldor,1 and

Andrew E. Grulich1

National Centres in 1HIV Epidemiology and Clinical Research and 2HIV Social Research, University of New South Wales, 3Sydney Sexual Health Centre, Sydney Hospital, and 4Sexually Transmitted Infections Research Centre, Westmead Hospital and University of Sydney, Sydney, 5Westmead Millennium Institute, Centre for Virus Research, Westmead Hospital, Westmead, and 6Taylor Square Private Clinic, Darlinghurst, New South Wales, Australia

Background.Despite increasing reports of herpes simplex virus (HSV) type 1 (HSV‐1)–associated anogenital herpes, there are very limited data comparing the seroepidemiological profile of and risk factors for HSV‐1 and HSV type 2 (HSV‐2) infection.

Methods.Sexual behaviors were examined as risk factors for prevalent and incident HSV‐1 and HSV‐2 infections in a community‐based cohort of 1427 HIV‐negative gay men in Australia.

Results.The prevalence of HSV‐1 and HSV‐2 at baseline was 75% and 23%, respectively. The rate of prevalent infection with HSV‐1, as well as the rate of prevalent infection with HSV‐2, was much lower in individuals <25 years of age, and each type of infection was associated with a higher number of both male and female sex partners. The median duration of follow‐up of the cohort was 2.0 years. Among participants who were susceptible to infection, the incidence rates for HSV‐1 and HSV‐2 infection were 5.58 and 1.45 cases per 100 person‐years, respectively. In multivariate analysis, incident infection with HSV‐1 was significantly associated with younger age ( ) and reports of frequent insertive oral sex with casual partners (hazard ratio, 3.91 [95% confidence interval, 1.23–12.44]; ). Incident infection with HSV‐2 was significantly associated with a variety of anal sex practices with casual partners.

Conclusions.Both HSV‐1 and HSV‐2 were commonly sexually transmitted, and there were more HSV‐1 than HSV‐2 seroconversions. Public‐health strategies targeted against anogenital herpes increasingly need to take into account the importance of HSV‐1 infection.

Received 26 March 2006; accepted 28 April 2006; electronically published 28 July 2006.

Reprints or correspondence: Mr. Fengyi Jin, National Centre in HIV Epidemiology and Clinical Research, Level 2, 376 Victoria St., Darlinghurst, NSW 2010, Australia ().

Cited by

I Mary Poynten, Fengyi Jin, Limin Mao, Garrett P Prestage, Susan C Kippax, John M Kaldor, John Imrie, Andrew E Grulich. (2009) Nonoccupational postexposure prophylaxis, subsequent risk behaviour and HIV incidence in a cohort of Australian homosexual men. AIDS 23:9, 1119-1126
Online publication date: 1-Jul-2009.
CrossRef
Garrett Prestage, Fengyi Jin, Susan Kippax, Iryna Zablotska, John Imrie, Andrew Grulich. (2009) Use of Illicit Drugs and Erectile Dysfunction Medications and Subsequent HIV Infection among Gay Men in Sydney, Australia. Journal of Sexual Medicine
Online publication date: 1-Jul-2009.
CrossRef
Andrew Page, Richard Taylor, Juliet Richters, Jonathan Shaw, Janette Taylor, Anthony Cunningham, Adrian Mindel. (2009) Upstairs and Downstairs. Sexually Transmitted Diseases 36:6, 344-349
Online publication date: 1-Jul-2009.
CrossRef
Jorge Sanchez, Javier R Lama, Jesus Peinado, Andres Paredes, Aldo Lucchetti, Kevin Russell, Tadeusz Kochel, Jose L Sebastian. (2009) High HIV and Ulcerative Sexually Transmitted Infection Incidence Estimates Among Men Who Have Sex With Men in Peru: Awaiting for an Effective Preventive Intervention. JAIDS Journal of Acquired Immune Deficiency Syndromes 51:Supplement 1, S47-S51
Online publication date: 1-Jun-2009.
CrossRef
Richard Brans, Natali V Akhrameyeva, Feng Yao. (2009) Prevention of Genital Herpes Simplex Virus Type 1 and 2 Disease in Mice Immunized with a gD-Expressing Dominant-Negative Recombinant HSV-1. Journal of Investigative Dermatology
Online publication date: 9-May-2009.
CrossRef
Fengyi Jin, June Crawford, Garrett P Prestage, Iryna Zablotska, John Imrie, Susan C Kippax, John M Kaldor, Andrew E Grulich. (2009) Unprotected anal intercourse, risk reduction behaviours, and subsequent HIV infection in a cohort of homosexual men. AIDS 23:2, 243-252
Online publication date: 1-Feb-2009.
CrossRef
Richard Brans, Elof Eriksson, Feng Yao. (2009) Immunization with a Dominant-Negative Recombinant HSV Type 1 Protects against HSV-1 Skin Disease in Guinea Pigs. Journal of Investigative Dermatology 128:12, 2825-2832
Online publication date: 1-Jan-2009.
CrossRef
Christopher K. Fairley, Andrew E. Grulich, John C. Imrie, Marian Pitts. (2008) Investment in HIV prevention works: a natural experiment. Sexual Health 5:2, 207
Online publication date: 1-Feb-2008.
CrossRef
Fengyi Jin, Garrett P. Prestage, Ann McDonald, Tim Ramacciotti, John C. Imrie, Susan C. Kippax, John M. Kaldor, Andrew E. Grulich. (2008) Trend in HIV incidence in a cohort of homosexual men in Sydney: data from the Health in Men Study. Sexual Health 5:2, 109
Online publication date: 1-Feb-2008.
CrossRef
John A. Schneider, Shaheen A. Alam, Marta Ackers, Bharat Parekh, Hua Yun Chen, Parrie Graham, Marc Gurwith, Kenneth Mayer, and Richard M. Novak. (2007) Mucosal HIV‐Binding Antibody and Neutralizing Activity in High‐Risk HIV‐Uninfected Female Participants in a Trial of HIV‐Vaccine Efficacy. The Journal of Infectious Diseases 196:11, 1637-1644
Online publication date: 1-Dec-2007.
Fengyi Jin, Garrett P. Prestage, Susan C. Kippax, Catherine M. Pell, Basil Donovan, David J. Templeton, John M. Kaldor, Andrew E. Grulich. (2006) Risk Factors for Genital and Anal Warts in a Prospective Cohort of HIV-Negative Homosexual Men: The HIM Study. Sexually Transmitted Diseases PAP,
Online publication date: 1-Dec-2006.
CrossRef
  • Financial support: The National Centre in HIV Epidemiology and Clinical Research and the National Centre in HIV Social Research are funded by the Australian Government Department of Health and Ageing. The project was funded by the Australian Government Department of Health and Ageing (Canberra) and the New South Wales Health Department (Sydney). The Health in Men Cohort Study was funded by the National Institutes of Health (NIH), a component of the US Department of Health and Human Services (NIH/National Institute of Allergy and Infectious Diseases/Division of AIDS: HVDDT award N01‐AI‐05395) and the National Health and Medical Research Council in Australia (grant 400944). Herpes testing was funded by GlaxoSmithKline.

    Potential conflicts of interest: D.J.T. and A.E.G. have received financial support for conference attendance and honorariums for educational activities from GlaxoSmithKline. All other authors: no conflicts.

Close Popup